CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
topical anesthetic +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00929071
NCT00929071N/ACompleted

Safety and Efficacy of the Addition of 0.3% Lidocaine With EVOLENCE®

Weinkle, Susan H., M.D.·interventional·Posted Jun 26, 2009·Updated Aug 7, 2014

In Brief

A clinical study evaluating Evolence, Lidocaine, and 1 other intervention for Aging and Pain. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The study doctor will give EVOLENCE® mixed with Lidocaine to people in this study to see if it effectively reduces pain while injecting and works to correct nasolabial wrinkles. The product being used in this study is EVOLENCE®, which is currently marketed in the United States for the cosmetic correction of soft tissue contour deficiencies (including wrinkles), and been approved by the U.S. Food and Drug Administration (FDA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging, Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 26, 2009
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2009
Study CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.0 years ago

Interventions

Evolencedevice

Injectable collagen

Lidocainedevice

admix anesthetic

topical anestheticdrug